C21 Investments Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Sonny Newman
- Full Time Employees
- 114
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- 601 West Cordova Vancouver BC Canada V6B 1G1
- IPO Date
- Jun 18, 2018
- Website
- cxxi.ca
- Similar Companies
- Business
- C21 Investments Inc. (CSE: CXXI) is a vertically integrated cannabis company that cultivates, processes, manufactures, and distributes quality cannabis and hemp-derived consumer products primarily in the United States. The company offers a broad portfolio of products including CO2 extracts, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk, wholesale, and packaged cannabis flowers; edibles; pre-rolls; tinctures; and topicals. It operates through key subsidiaries such as Silver State Relief and Silver State Cultivation in Nevada, along with legacy Oregon brands including Phantom Farms, Hood Oil, and Eco Firma Farms, serving retail dispensaries, wholesale markets, and medical cannabis customers with a focus on THC and CBD offerings. Founded in 1987 and headquartered in Vancouver, Canada, C21 Investments previously operated as Curlew Lake Resources Inc. before changing its name in November 2017; the company maintains approximately 114 employees and reports in U.S. dollars with a fiscal year ending March. In recent developments, C21 Investments closed the acquisition of a 6,500 square-foot cannabis dispensary in Reno, Nevada, in June 2024 to expand its retail channels and support increased cultivation output. The company completed a non-dilutive issuance of 100 million subordinate voting shares in September 2025 to its CFO to preserve its U.S. Foreign Private Issuer status and reduce compliance costs, while also settling litigation related to Eco Firma Farms in the same month. Additional strategic moves include repurchasing 2,051,000 common shares for cancellation in February 2025 under a Normal Course Issuer Bid announced in November 2024, alongside ongoing cultivation facility expansions in Nevada and consistent revenue growth reported in quarterly results through Q2 2025.
Company News
C21 Shareholders Approve Arrangement with Vireo Growth Inc.
Vireo Growth Inc. and C21 Investments Inc. Announce Definitive Arrangement Agreement
C21 Investments Announces Renewed Normal Course Issuer Bid
C21 Investments to Report Second Quarter Financial Results on November 11, 2025
C21 Investments Announces Settlement of Eco Firma Farms Litigation
C21 Investments Announces Q2 Earnings Date and Provides Operational Update
C21 Investments Provides MCTO Status Update
C21 Investments Provides MCTO Status Update
Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management
C21 Investments Provides MCTO Status Update
C21 Investments Announces Change to Financial Year-End, Delay in Filing Annual Financial Results and Application for Management Cease Trade Order
C21 Announces Closing of C$4 Million Private Placement of Convertible Debenture Units
Reasons To Be Cautiously Optimistic About Cannabis
C21 Investments Reports Slightly Lower Q3 Revenue, 10th Straight Quarter Of Positive Free Cash Flow
C21 Announces Release Date of Fiscal Year End Financial Results
5 Reasons Why C21 Investments Is Ready To Take On The Big Cannabis MSOs
C21 Investments Checks All The Boxes And Is Profitable; It Is Love At First Sight